Brief: Noxopharm Appoints Gisela Mautner As Chief Executive Officer
05/01/2022 01:09
Jan 5 (Reuters) - Noxopharm Ltd NOX.AX :
* APPOINTMENT OF GISELA MAUTNER AS CHIEF EXECUTIVE OFFICER
* GISELA MAUTNER WILL SERVE ON BOARD AS EXECUTIVE MANAGING
DIRECTOR
Source text for Eikon: ID:nASX7vp4hq
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential